• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国退伍军人2型糖尿病患者非严重低血糖的发生率及治疗强度:一项前瞻性观察研究。

Incidence of non-severe hypoglycaemia and intensity of treatment among veterans with type 2 diabetes in the U.S.A.: a prospective observational study.

作者信息

Wendel C S, Fotieo G G, Shah J H, Felicetta J, Curtis B H, Murata G H

机构信息

Southern Arizona VA Health Care System and University of Arizona College of Medicine, Tucson, AZ, USA.

出版信息

Diabet Med. 2014 Dec;31(12):1524-31. doi: 10.1111/dme.12543. Epub 2014 Jul 22.

DOI:10.1111/dme.12543
PMID:24975871
Abstract

AIM

To quantify the incidence of non-severe hypoglycaemic events among veterans with Type 2 diabetes and its association with primary care provider prescribing behaviour.

METHODS

This was a prospective observational study involving 30 primary care providers and patients enrolled with these primary care providers, identified from computerized pharmacy records. Two sampling frames were created consisting of (1) patients not treated with insulin and receiving sulfonylurea treatment (with or without other oral hypoglycaemic agents) and (2) patients treated with insulin (with or without sulfonylureas or other oral hypoglycaemic agents). Patients recorded the frequency, proximal cause of, and response to each hypoglycaemic event over a 12-week period and made three visits to a research coordinator over 24 weeks. Data were provided to the primary care provider before their next visit and charts were reviewed for medication changes.

RESULTS

A total of 265 patients were enrolled in study. During the 12 weeks of structured self-monitoring of blood glucose, patients recorded a mean (sd) of 6.9 (10.3) hypoglycaemic events. Duration of diabetes increased monotonically with increasing category of hypoglycaemic event (P < 0.001). Among insulin users, an increased frequency of hypoglycaemic events was associated with a decreased likelihood of dose intensification by primary care providers (relative risk 0.86 per event; P = 0.02) but no significant increase in tendency for dose reduction (relative risk 1.04 per event; P = 0.06). Increased frequency of hypoglycaemic events was associated with an increased likelihood of dose reduction (relative risk 1.12 per event; P = 0.03) in the sulfonylurea treatment group.

CONCLUSIONS

Non-severe hypoglycaemia is common among veterans with Type 2 diabetes receiving insulin or sulfonylureas and influences the prescribing behaviour of primary care providers.

摘要

目的

量化2型糖尿病退伍军人中非严重低血糖事件的发生率及其与初级保健提供者处方行为的关联。

方法

这是一项前瞻性观察性研究,涉及30名初级保健提供者以及在这些初级保健提供者处登记的患者,这些患者从计算机化药房记录中识别出来。创建了两个抽样框架,分别为:(1)未接受胰岛素治疗且接受磺脲类治疗(无论是否使用其他口服降糖药)的患者;(2)接受胰岛素治疗的患者(无论是否使用磺脲类药物或其他口服降糖药)。患者记录了12周内每次低血糖事件的发生频率、近端原因及应对措施,并在24周内三次拜访研究协调员。在下一次就诊前将数据提供给初级保健提供者,并审查病历以了解用药变化情况。

结果

共有265名患者纳入研究。在12周的结构化血糖自我监测期间,患者记录的低血糖事件平均(标准差)次数为6.9(10.3)次。糖尿病病程随低血糖事件类别增加而单调增加(P<0.001)。在胰岛素使用者中,低血糖事件发生频率增加与初级保健提供者增加剂量的可能性降低相关(每次事件相对风险为0.86;P=0.02),但减少剂量的趋势无显著增加(每次事件相对风险为1.04;P=0.06)。在磺脲类治疗组中,低血糖事件发生频率增加与减少剂量的可能性增加相关(每次事件相对风险为1.12;P=0.03)。

结论

接受胰岛素或磺脲类治疗的2型糖尿病退伍军人中,非严重低血糖很常见,且会影响初级保健提供者的处方行为。

相似文献

1
Incidence of non-severe hypoglycaemia and intensity of treatment among veterans with type 2 diabetes in the U.S.A.: a prospective observational study.美国退伍军人2型糖尿病患者非严重低血糖的发生率及治疗强度:一项前瞻性观察研究。
Diabet Med. 2014 Dec;31(12):1524-31. doi: 10.1111/dme.12543. Epub 2014 Jul 22.
2
Hypoglycaemia in the over 75s: Understanding the predisposing factors in type 2 diabetes (T2DM).75岁以上人群的低血糖:了解2型糖尿病(T2DM)的诱发因素。
Prim Care Diabetes. 2018 Apr;12(2):133-138. doi: 10.1016/j.pcd.2017.08.002. Epub 2017 Sep 20.
3
Real-world patient-reported rates of non-severe hypoglycaemic events in Germany.德国真实世界中患者报告的非严重低血糖事件发生率。
Exp Clin Endocrinol Diabetes. 2014 Mar;122(3):167-72. doi: 10.1055/s-0033-1363688. Epub 2014 Mar 18.
4
Risk of hypoglycemia following intensification of metformin treatment with insulin versus sulfonylurea.与磺脲类药物相比,胰岛素强化二甲双胍治疗后发生低血糖的风险。
CMAJ. 2016 Apr 5;188(6):E104-E112. doi: 10.1503/cmaj.150904. Epub 2016 Jan 25.
5
Assessing potential glycemic overtreatment in persons at hypoglycemic risk.评估低血糖风险人群中潜在的过度血糖治疗。
JAMA Intern Med. 2014 Feb 1;174(2):259-68. doi: 10.1001/jamainternmed.2013.12963.
6
Self-reported non-severe hypoglycaemic events in Europe.欧洲自我报告的非严重低血糖事件。
Diabet Med. 2014 Jan;31(1):92-101. doi: 10.1111/dme.12261. Epub 2013 Jul 26.
7
Comparative Effectiveness of Insulin versus Combination Sulfonylurea and Insulin: a Cohort Study of Veterans with Type 2 Diabetes.胰岛素与磺脲类药物联合胰岛素的比较疗效:一项2型糖尿病退伍军人队列研究。
J Gen Intern Med. 2016 Jun;31(6):638-46. doi: 10.1007/s11606-016-3633-2.
8
Changes in incidence of severe hypoglycaemia in people with type 2 diabetes from 2006 to 2016: analysis based on health insurance data in Germany considering the anti-hyperglycaemic medication.2006年至2016年2型糖尿病患者严重低血糖发生率的变化:基于德国医疗保险数据并考虑降糖药物的分析
Diabet Med. 2020 Aug;37(8):1326-1332. doi: 10.1111/dme.14294. Epub 2020 Mar 20.
9
Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study.来自24个国家的27585例接受胰岛素治疗的1型和2型糖尿病患者低血糖的发生率及预测因素:全球HAT研究
Diabetes Obes Metab. 2016 Sep;18(9):907-15. doi: 10.1111/dom.12689. Epub 2016 Jun 20.
10
Differential associations of risk factors with severe and non-severe hypoglycaemia: the Hypoglycaemia Assessment Tool prospective observational study in people with insulin-treated type 1 diabetes and type 2 diabetes.不同危险因素与严重和非严重低血糖的关联:胰岛素治疗的 1 型糖尿病和 2 型糖尿病患者低血糖评估工具前瞻性观察研究。
Diabetes Obes Metab. 2024 Aug;26(8):3361-3370. doi: 10.1111/dom.15677. Epub 2024 Jun 3.

引用本文的文献

1
Nonsevere Hypoglycemia Episode Clinical and Economic Outcomes: A Comparison between Sulfonylurea and Sodium-Glucose Cotransporter 2 Inhibitor as Add-On to Metformin from a Canadian Perspective.非严重低血糖事件的临床和经济结果:从加拿大视角比较磺脲类药物和钠-葡萄糖协同转运蛋白2抑制剂作为二甲双胍附加治疗的情况
Int J Endocrinol. 2018 Jul 8;2018:3718958. doi: 10.1155/2018/3718958. eCollection 2018.
2
HbA1c and hypoglycaemia in intensively treated type 2 diabetes: a retrospective cohort study in primary care.强化治疗的2型糖尿病患者的糖化血红蛋白与低血糖:一项初级保健中的回顾性队列研究
JRSM Open. 2018 Jul 6;9(7):2054270418773669. doi: 10.1177/2054270418773669. eCollection 2018 Jul.
3
Perceptions of insulin use in type 2 diabetes in primary care: a thematic synthesis.
基层医疗中2型糖尿病患者对胰岛素使用的认知:一项主题综合分析
BMC Fam Pract. 2018 May 22;19(1):70. doi: 10.1186/s12875-018-0753-2.
4
Protective effects of vascular endothelial growth factor in cultured brain endothelial cells against hypoglycemia.血管内皮生长因子对培养的脑内皮细胞抗低血糖的保护作用。
Metab Brain Dis. 2015 Aug;30(4):999-1007. doi: 10.1007/s11011-015-9659-z. Epub 2015 Mar 13.
5
Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes.避免或应对2型糖尿病患者的严重低血糖
Korean J Intern Med. 2015 Jan;30(1):6-16. doi: 10.3904/kjim.2015.30.1.6. Epub 2014 Dec 30.